http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2209636-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d12b35c0dd9adfb167b3b4f383afe93
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-164
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-164
filingDate 2002-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2005-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_013155ebbe33fa9a82618994cf35ef5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fc790b77402d7465a17c77df8e99e3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2abbc1358cdd11624fd87552f6ab24dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9274be67c376128bf529261b9fc06f9a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_369d69ce24328be39dc484be4efe8e07
publicationDate 2005-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2209636-B1
titleOfInvention CYCLIC DEPSIPEPTIDE AS A CHEMOTHERAPEUTIC AGENT AGAINST CANCER.
abstract Cyclic depsypeptide as agentnChemotherapeutic cancer.n n n Serratamolide, also called the [(3R) -3-hydroxidecanoyl-L-seryl- (3R) -3-hydroxidecanoyl-L-seryl] cycle, is a cyclic depsypeptide isolated from bacteria cultures of the Serratia marcescens species. Serratamolide decreases the viability of several cancer cells (leukemias, myelomas, carcinomas, etc.) and induces apoptosis in them, with virtually no effect on non-cancerous cells. This makes serratamolide, and its pharmaceutically acceptable addition salts and / or solvates, useful as an anticancer chemotherapeutic agent, particularly against leukemia, lymphoma, myeloma, carcinoma, melanoma and sarcoma.
priorityDate 2002-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP06873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26612
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID167917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415737932
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID615
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP36375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558593
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16218671
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID167917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426148219
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID615
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408715214
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168994
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414805975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415861823
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582665
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135408511
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123132
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426084220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5352062

Total number of triples: 41.